NEW YORK (GenomeWeb) – Signal Genetics said after the close of the market on Thursday that its first quarter revenues dropped 41 percent year over year. 

The Carlsbad, California-based molecular diagnostics firm recorded $645,000 in revenues for the three months ended March 31, down from $1.1 million in the year-ago quarter. The firm said that the decrease was driven by a drop in the number of tests billed for University of Arkansas for Medical Sciences research and clinical patients at the hospital. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.